Oral Tranexamic Acid for Melasma: What Studies Show and the Clot Checks First
SkinArticleMelasma's brown facial patches can persist into your 50s and beyond. Some dermatologists now prescribe low-dose tranexamic acid pills, a medicine approved for heavy periods, off-label. Small trials show the patches fade, but the label's clot warnings mean careful screening matters.

In this article
Melasma causes brown or gray-brown patches on the cheeks, forehead or upper lip. It’s more common in people with darker skin tones,1 and it can linger for years. When creams and sunscreen haven’t been enough, some dermatologists prescribe tranexamic acid pills, a use that’s off-label.
What it’s approved for
Tranexamic acid tablets are FDA-approved for heavy menstrual bleeding, at a much higher dose (1,300 mg three times a day for up to 5 days a month).2 For melasma, studies have used far lower daily doses over several months.31
What studies show
- A U.S. randomized trial gave 250 mg twice a day or placebo for 3 months, along with sunscreen. Melasma scores dropped 49% with tranexamic acid versus 18% with placebo. Three months after stopping, part of the gain was lost: 26% below baseline versus 19%.3 No serious side effects were seen, but the trial was small (39 completed) and mostly included Hispanic women.3
- A 2017 meta-analysis of 11 studies and 667 people found tranexamic acid reduced melasma, alone or added to other treatments. Side effects were minor, such as lighter periods, mild stomach upset and skin irritation.4
- A 2018 review suggested considering it when about 12 weeks of creams such as hydroquinone haven’t worked.1
The clot checks
Tranexamic acid helps blood clots hold together. The approved label says not to use it with:2
- a current or past blood clot, including in the eye’s blood vessels
- an inherited or other built-in tendency to clot
- combined hormonal birth control
The melasma review said studies haven’t shown a higher clot risk at low doses, but people should be carefully screened for risk factors first.1 After 50, that includes talking about hormone therapy, past clots, heart rhythm problems and recent surgery. Kidney problems may require a lower dose.2 Our article on estrogen pills, patches and clot risk explains why the form of hormone therapy matters.
Sun protection still matters
Daily sunscreen was part of the trial treatment.3 Our guides to choosing sunscreen, age spots and mercury in dark-spot creams cover other steps.
Questions to ask
- Is this melasma, or another kind of dark spot?
- Do I have any clot risk factors that rule this out?
- What dose and how long, and what happens when I stop?
- Should I keep my creams going at the same time?
Try: “My melasma hasn’t improved with creams. Would low-dose tranexamic acid be safe for me, given that I’m on hormone therapy?”
Skin, Head to Toe includes a short-shelf planner and a 12-week SkinLog. Use them to take monthly photos in the same light and track every product you use. See the book.
This article is for general educational purposes only and is not medical advice. It isn't a substitute for diagnosis or treatment from a qualified healthcare professional who knows your health history. Please don't start, stop or change a prescription medicine without talking to your prescriber. Seek emergency care for leg swelling or pain, sudden shortness of breath, chest pain, sudden vision loss, or stroke symptoms. A new or changing dark spot should be checked by a dermatologist. If you think you may be having a medical emergency, call 911 or your local emergency number right away. This article discusses a prescription medicine and published research. Girl Playbook does not endorse any specific product, test, or provider.
Girl Playbook sells this book. It provides education and worksheets, not individualized medical care.
Sources
The research behind this article, in the order it’s cited. How we source our articles.
- Dermatologic Surgery (abstract via Europe PMC), 2018Oral Tranexamic Acid for the Treatment of Melasma: A Review (opens in a new tab)abcd
- DailyMed, National Library of MedicineTranexamic acid tablets: prescribing information (opens in a new tab)abc
- Journal of the American Academy of Dermatology (abstract via Europe PMC), 2018Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma (opens in a new tab)abcd
- Acta Dermato-Venereologica (abstract via Europe PMC), 2017Efficacy and Safety of Tranexamic Acid in Melasma: A Meta-analysis and Systematic Review (opens in a new tab)↩
Spotted something out of date? Tell us and we’ll check it.


